Cansortium Inc. (OTCMKTS:CNTMF) Short Interest Down 83.9% in June

Cansortium Inc. (OTCMKTS:CNTMF) was the target of a significant decrease in short interest in June. As of June 30th, there was short interest totaling 41,835 shares, a decrease of 83.9% from the June 15th total of 260,061 shares. Based on an average trading volume of 1,061,571 shares, the days-to-cover ratio is currently 0.0 days.

Cansortium Trading Down 1.4%

Cansortium stock traded down $0.00 during midday trading on Friday, reaching $0.02. 652,397 shares of the company were exchanged, compared to its average volume of 454,394. The firm’s 50-day simple moving average is $0.02 and its 200-day simple moving average is $0.03. Cansortium has a 1 year low of $0.02 and a 1 year high of $0.09.

Cansortium (OTCMKTS:CNTMF) last announced its earnings results on Thursday, April 30th. The company reported ($0.16) earnings per share for the quarter. During the same quarter in the previous year, the business earned ($0.14) EPS.

About Cansortium

Cansortium, Inc (OTCMKTS:CNTMF) is a vertically integrated cannabis company engaged in the cultivation, manufacturing, distribution and retail of medical cannabis products in the United States. The company’s operations span from seed to sale, with dedicated cultivation facilities, extraction labs and a network of dispensaries serving registered patients.

Cansortium holds licenses and operates in multiple jurisdictions, including Florida, Pennsylvania, Louisiana, Texas and Puerto Rico. Its product portfolio encompasses cannabis flower, pre-rolls, concentrates, vape cartridges, oils, edibles and topicals, offered under brands such as The+Source, Chroma and Campfire, alongside its private-label formulations.

Founded in 2017 and headquartered in Miami, Cansortium began dispensary operations in Florida in 2018 and has since expanded its footprint into new markets.